816 related articles for article (PubMed ID: 33183286)
1. Exosome-based immunotherapy: a promising approach for cancer treatment.
Xu Z; Zeng S; Gong Z; Yan Y
Mol Cancer; 2020 Nov; 19(1):160. PubMed ID: 33183286
[TBL] [Abstract][Full Text] [Related]
2. Exosome-based anticancer vaccines: From Bench to bedside.
Zhao G; Wang Y; Xing S; Jiang Y; Ding J; Cai Y; Ma P; Miao H; Fang Y; Jiang N; Cui D; Yu Y; Tang Q; Wang S; Li N
Cancer Lett; 2024 Jul; 595():216989. PubMed ID: 38825162
[TBL] [Abstract][Full Text] [Related]
3. How can nanotechnology help membrane vesicle-based cancer immunotherapy development?
Tian X; Zhu M; Nie G
Hum Vaccin Immunother; 2013 Jan; 9(1):222-5. PubMed ID: 23108359
[TBL] [Abstract][Full Text] [Related]
4. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
Sundararajan V; Sarkar FH; Ramasamy TS
Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy.
Srivastava A; Rathore S; Munshi A; Ramesh R
AAPS J; 2021 Feb; 23(2):30. PubMed ID: 33586060
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy.
Naseri M; Bozorgmehr M; Zöller M; Ranaei Pirmardan E; Madjd Z
Oncoimmunology; 2020 Jun; 9(1):1779991. PubMed ID: 32934883
[TBL] [Abstract][Full Text] [Related]
7. Exosomes in Tumor Immunotherapy: Mediator, Drug Carrier, and Prognostic Biomarker.
Wan Z; Dong Y; Wei M; Gao X; Yang G; Zhang J; Liu L
Adv Biosyst; 2020 Nov; 4(11):e2000061. PubMed ID: 32700829
[TBL] [Abstract][Full Text] [Related]
8. The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.
Alfonsi R; Grassi L; Signore M; Bonci D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652798
[TBL] [Abstract][Full Text] [Related]
9. Harnessing the exosome-induced immune response for cancer immunotherapy.
Gehrmann U; Näslund TI; Hiltbrunner S; Larssen P; Gabrielsson S
Semin Cancer Biol; 2014 Oct; 28():58-67. PubMed ID: 24859748
[TBL] [Abstract][Full Text] [Related]
10. Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications.
Jung I; Shin S; Baek MC; Yea K
Exp Mol Med; 2024 Feb; 56(1):19-31. PubMed ID: 38172594
[TBL] [Abstract][Full Text] [Related]
11. Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.
Syn NL; Wang L; Chow EK; Lim CT; Goh BC
Trends Biotechnol; 2017 Jul; 35(7):665-676. PubMed ID: 28365132
[TBL] [Abstract][Full Text] [Related]
12. Roles of exosomes in immunotherapy for solid cancers.
Lyu C; Sun H; Sun Z; Liu Y; Wang Q
Cell Death Dis; 2024 Feb; 15(2):106. PubMed ID: 38302430
[TBL] [Abstract][Full Text] [Related]
13. Designer exosomes as next-generation cancer immunotherapy.
Bell BM; Kirk ID; Hiltbrunner S; Gabrielsson S; Bultema JJ
Nanomedicine; 2016 Jan; 12(1):163-9. PubMed ID: 26500074
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in exosome-based immunotherapy applied to cancer.
Xie J; Zheng Z; Tuo L; Deng X; Tang H; Peng C; Zou Y
Front Immunol; 2023; 14():1296857. PubMed ID: 38022585
[TBL] [Abstract][Full Text] [Related]
15. Exosomes-Small Players, Big Sound.
Gulei D; Irimie AI; Cojocneanu-Petric R; Schultze JL; Berindan-Neagoe I
Bioconjug Chem; 2018 Mar; 29(3):635-648. PubMed ID: 29369619
[TBL] [Abstract][Full Text] [Related]
16. Exosomes as drug delivery systems in glioma immunotherapy.
Hao X; Wang S; Wang L; Li J; Li Y; Liu J
J Nanobiotechnology; 2024 Jun; 22(1):340. PubMed ID: 38890722
[TBL] [Abstract][Full Text] [Related]
17. The function and clinical application of extracellular vesicles in innate immune regulation.
Zhou X; Xie F; Wang L; Zhang L; Zhang S; Fang M; Zhou F
Cell Mol Immunol; 2020 Apr; 17(4):323-334. PubMed ID: 32203193
[TBL] [Abstract][Full Text] [Related]
18. Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences.
Chung CK; Da Silva CG; Kralisch D; Chan A; Ossendorp F; Cruz LJ
J Control Release; 2018 Sep; 285():56-66. PubMed ID: 30008371
[TBL] [Abstract][Full Text] [Related]
19. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
[TBL] [Abstract][Full Text] [Related]
20. Milk Exosomes: Perspective Agents for Anticancer Drug Delivery.
Sedykh S; Kuleshova A; Nevinsky G
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]